Nielsen BioSciences Revenue and Competitors
Estimated Revenue & Valuation
- Nielsen BioSciences's estimated annual revenue is currently $1.9M per year.
- Nielsen BioSciences's estimated revenue per employee is $155,000
Employee Data
- Nielsen BioSciences has 12 Employees.
- Nielsen BioSciences grew their employee count by 0% last year.
Nielsen BioSciences's People
Name | Title | Email/Phone |
---|---|---|
1 | Director, Quality and Regulatory | Reveal Email/Phone |
2 | Associate Director, Quality and Regulatory | Reveal Email/Phone |
3 | Facility and Equipment Manager | Reveal Email/Phone |
4 | Quality Control Manager | Reveal Email/Phone |
Nielsen BioSciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Nielsen BioSciences?
Nielsen BioSciences, Inc. is a private, San Diego-based biotechnology company focused on offering medical professionals trusted and valued biological products with wide-ranging applications of cell-mediated immune responses. We are building on a solid foundation of over 40 years developing and delivering antigen-based products. Our research and development leverages heterogeneous antigenic profiles to enlist cell-mediated immunity in the evaluation, treatment, or prevention of diseases. Antigenic diversity enables us to effectively address conditions missed by narrowly targeted strategies
keywords:N/AN/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1M | 12 | 9% | N/A |
#2 | $1M | 12 | N/A | N/A |
#3 | $1M | 12 | N/A | N/A |
#4 | $1.8M | 12 | N/A | N/A |
#5 | $1M | 12 | N/A | N/A |